1.Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila.
Michael F WANGLER ; Lawrence T REITER ; Georgianna ZIMM ; Jennifer TRIMBLE-MORGAN ; Jane WU ; Ethan BIER
Protein & Cell 2011;2(7):554-563
Alzheimer's disease (AD) pathogenesis is characterized by senile plaques in the brain and evidence of oxidative damage. Oxidative stress may precede plaque formation in AD; however, the link between oxidative damage and plaque formation remains unknown. Presenilins are transmembrane proteins in which mutations lead to accelerated plaque formation and early-onset familial Alzheimer's disease. Presenilins physically interact with two antioxidant enzymes thiol-specific antioxidant (TSA) and proliferation-associated gene (PAG) of the peroxiredoxin family. The functional consequences of these interactions are unclear. In the current study we expressed a presenilin transgene in Drosophila wing and sensory organ precursors of the fly. This caused phenotypes typical of Notch signaling loss-of-function mutations. We found that while expression of TSA or PAG alone produced no phenotype, co-expression of TSA and PAG with presenilin led to an enhanced Notch loss-of-function phenotype. This phenotype was more severe and more penetrant than that caused by the expression of Psn alone. In order to determine whether these phenotypes were indeed affecting Notch signaling, this experiment was performed in a genetic background carrying an activated Notch (Abruptex) allele. The phenotypes were almost completely rescued by this activated Notch allele. These results link peroxiredoxins with the in vivo function of Presenilin, which ultimately connects two key pathogenetic mechanisms in AD, namely, antioxidant activity and plaque formation, and raises the possibility of a role for peroxiredoxin family members in Alzheimer's pathogenesis.
Amino Acid Sequence
;
Animals
;
Drosophila
;
metabolism
;
physiology
;
Drosophila Proteins
;
metabolism
;
Molecular Sequence Data
;
Peroxiredoxins
;
chemistry
;
genetics
;
metabolism
;
Presenilins
;
chemistry
;
metabolism
;
Receptors, Notch
;
metabolism
;
Sequence Alignment
;
Signal Transduction
2.CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study.
Igor TSAUR ; Anika NOACK ; Jasmina MAKAREVIC ; Elsie OPPERMANN ; Ana Maria WAAGA-GASSER ; Martin GASSER ; Hendrik BORGMANN ; Tanja HUESCH ; Kilian M GUST ; Michael REITER ; David SCHILLING ; Georg BARTSCH ; Axel HAFERKAMP ; Roman A BLAHETA
Cancer Research and Treatment 2015;47(2):306-312
PURPOSE: Prostate specific antigen is not reliable in diagnosing prostate cancer (PCa), making the identification of novel, precise diagnostic biomarkers important. Since chemokines are associated with more aggressive disease and poor prognosis in diverse malignancies, we aimed to investigate the diagnostic relevance of chemokines in PCa. MATERIALS AND METHODS: Preoperative and early postoperative serum samples were obtained from 39 consecutive PCa patients undergoing radical prostatectomy. Serum from 15 healthy volunteers served as controls. Concentrations of CXCL12, CXCL13, CX3CL1, CCL2, CCL5, and CCL20 were measured in serum by Luminex. The expression activity of CXCR3, CXCR4, CXCR5, CXCR7, CXCL12, CXCL13, CX3CR1, CXCL1, CCR2, CCR5, CCR6, CCR7, CCL2, and CCL5 mRNA was assessed in tumor and adjacent normal tissue of prostatectomy specimens by quantitative real-time polymerase chain reaction. The associations of these chemokines with clinical and histological parameters were tested. RESULTS: The gene expression activity of CCL2 and CCR6 was significantly higher in tumor tissue compared to adjacent normal tissue. CCL2 was also significantly higher in the blood samples of PCa patients, compared to controls. CCL5, CCL20, and CX3CL1 were lower in patient serum, compared to controls. CCR2 tissue mRNA was negatively correlated with the Gleason score and grading. CONCLUSION: Chemokines are significantly modified during tumorigenesis of PCa, and CCL2 is a promising diagnostic biomarker.
Biological Markers
;
Carcinogenesis
;
Chemokine CCL2*
;
Chemokines
;
Diagnosis
;
Gene Expression
;
Healthy Volunteers
;
Humans
;
Neoplasm Grading
;
Passive Cutaneous Anaphylaxis
;
Pilot Projects*
;
Prognosis
;
Prostate-Specific Antigen
;
Prostatectomy
;
Prostatic Neoplasms*
;
Real-Time Polymerase Chain Reaction
;
RNA, Messenger